Pretreatment with gigantol decreased the levels of cancer stem cell markers, including prominin-1 (CD133) and aldehyde dehydrogenase 1 family member 1A (ALDH1A1), in A549, H460, and H292 cells. Here, PROM1 is linked to cancer.